business, pharma, biotech

Some say the biotech bubble has burst over concerns that drug prices are too high—and may soon be regulated.

The pharma giant strikes a deal to acquire InterMune, a Brisbane, California-based biotech with only one product—a treatment for a fatal lung disease.

How to successfully surmount the challenges women face in becoming biotech industry leaders